Literature DB >> 32671893

Electromagnetic Nanomedicines for Combinational Cancer Immunotherapy.

Jingchao Li1, Yu Luo2, Kanyi Pu1.   

Abstract

Immunotherapy that harnesses the power of the immune system to eliminate malignant cells has offered an effective approach for cancer treatment. However, limited patient response rates and potential immune-related adverse events exist as two major issues for cancer immunotherapy. In parallel, a variety of electromagnetic nanomaterials that generate heat and/or reactive oxygen species triggered by electromagnetic energy have been applied for magnetic hyperthermia therapy, sonodynamic therapy, photothermal therapy, photodynamic therapy, and radiotherapy, which have the ability to induce immunogenic cell death. This review summarizes the recent development of electromagnetic nanomedicines in combinational cancer immunotherapy. The mechanisms of electromagnetic nanomedicines in reprogramming the immunosuppressive tumor microenvironment and sensitizing tumors for cancer immunotherapy are highlighted. Furthermore, potential challenges and perspectives of electromagnetic nanomedicines for combinational cancer immunotherapy are discussed.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  cancer therapy; electromagnetic energy; immunogenic cell death; immunotherapy; nanomedicine

Year:  2021        PMID: 32671893     DOI: 10.1002/anie.202008386

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  12 in total

1.  Amelioration of systemic antitumor immune responses in cocktail therapy by immunomodulatory nanozymes.

Authors:  Shuren Wang; Zhiyi Wang; Ziyuan Li; Xiaoguang Zhang; Hongtao Zhang; Teng Zhang; Xiangxi Meng; Fugeng Sheng; Yanglong Hou
Journal:  Sci Adv       Date:  2022-05-27       Impact factor: 14.957

Review 2.  Recent Advances in Engineering Nanomedicines for Second Near-Infrared Photothermal-Combinational Immunotherapy.

Authors:  Fengshuo Wang; Jingyi Zhu; Yongtao Wang; Jingchao Li
Journal:  Nanomaterials (Basel)       Date:  2022-05-12       Impact factor: 5.719

Review 3.  Near-Infrared Photoactivatable Immunomodulatory Nanoparticles for Combinational Immunotherapy of Cancer.

Authors:  Ningyue Yu; Mengbin Ding; Jingchao Li
Journal:  Front Chem       Date:  2021-05-24       Impact factor: 5.221

4.  Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy.

Authors:  Meixiao Zhan; Xiangrong Yu; Wei Zhao; Yongjun Peng; Shaojun Peng; Jingchao Li; Ligong Lu
Journal:  J Nanobiotechnology       Date:  2022-01-06       Impact factor: 10.435

5.  Engineered extracellular vesicle-based sonotheranostics for dual stimuli-sensitive drug release and photoacoustic imaging-guided chemo-sonodynamic cancer therapy.

Authors:  Thuy Giang Nguyen Cao; Ji Hee Kang; Wangyu Kim; Junha Lim; Su Jin Kang; Jae Young You; Quan Truong Hoang; Won Jong Kim; Won Jong Rhee; Chulhong Kim; Young Tag Ko; Min Suk Shim
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

Review 6.  Redox dyshomeostasis strategy for tumor therapy based on nanomaterials chemistry.

Authors:  Yelin Wu; Yanli Li; Guanglei Lv; Wenbo Bu
Journal:  Chem Sci       Date:  2022-01-12       Impact factor: 9.825

7.  Catalytical nano-immunocomplexes for remote-controlled sono-metabolic checkpoint trimodal cancer therapy.

Authors:  Chi Zhang; Jingsheng Huang; Ziling Zeng; Shasha He; Penghui Cheng; Jingchao Li; Kanyi Pu
Journal:  Nat Commun       Date:  2022-06-16       Impact factor: 17.694

Review 8.  Tumor extracellular matrix modulating strategies for enhanced antitumor therapy of nanomedicines.

Authors:  Meng Li; Yijing Zhang; Qin Zhang; Jingchao Li
Journal:  Mater Today Bio       Date:  2022-07-15

9.  Erythrocyte-Camouflaged Mesoporous Titanium Dioxide Nanoplatform for an Ultrasound-Mediated Sequential Therapies of Breast Cancer.

Authors:  Qunying Li; Bin Lin; Yongzhou Li; Nan Lu
Journal:  Int J Nanomedicine       Date:  2021-06-08

Review 10.  Bioenzyme-based nanomedicines for enhanced cancer therapy.

Authors:  Mengbin Ding; Yijing Zhang; Jingchao Li; Kanyi Pu
Journal:  Nano Converg       Date:  2022-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.